0548 GMT - Thomson Medical Group is unlikely to turn profitable in the short term, Maybank Research's Eric Ong says in a report. The Singapore-listed company posted a fiscal 1H net loss of S$12.9 million, with the magnitude of the loss catching the analyst off guard. The poor performance of its Malaysian operations and increased interest expenses related to the acquisition of FV Hospital in Vietnam were the main contributors. The healthcare-services provider probably needs more time to fully reap the benefits of maximizing its assets and enhancing margins in its key markets, Ong adds. The brokerage downgrades the stock to hold from buy and cuts the target price to S$0.05 from S$0.06. Shares are 2.2% lower at S$0.044. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
February 14, 2025 00:48 ET (05:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。